论文部分内容阅读
目的 :探讨美洛昔康应用于慢性前列腺炎治疗中的临床效果。方法 :将300例慢性前列腺炎患者依治疗方法不同分为A组(行使美洛昔康+左氧氟沙星联合治疗)和B组(单用左氧氟沙星治疗),每组各有150例慢性前列腺炎患者。结果 :A组慢性前列腺炎患者治疗有效率90.67%明显高于B组慢性前列腺炎患者治疗有效率84.67%,(P<0.05)。结论 :和单用左氧氟沙星相比,美洛昔康+左氧氟沙星联合治疗在慢性前列腺炎患者中进行应用,有着相对较高的治疗有效率,值得进一步推广和研究。
Objective: To investigate the clinical effect of meloxicam in the treatment of chronic prostatitis. Methods: Three hundred patients with chronic prostatitis were divided into group A (combined with meloxicam + levofloxacin) and group B (levofloxacin alone) according to the different treatment methods. There were 150 patients with chronic prostatitis in each group. Results: The effective rate of treatment in chronic prostatitis group A was 90.67%, which was significantly higher than that in group B chronic prostatitis (84.67%, P <0.05). Conclusions: Compared with levofloxacin alone, the combination of meloxicam and levofloxacin in patients with chronic prostatitis has a relatively high therapeutic efficiency and worthy of further promotion and research.